cllsociety.org

Website beoordeling cllsociety.org

CLL Society, the Leading Authority for CLL and SLL Patients

 Gegenereerd op Maart 20 2026 07:16 AM

Oude statistieken? UPDATE !

De score is 54/100

SEO Content

Title

CLL Society, the Leading Authority for CLL and SLL Patients

Lengte : 59

Perfect, uw title tag bevat tussen de 10 en 70 karakters.

Description

CLL Society is devoted to serving chronic lymphocytic leukemia and small lymphocytic lymphoma cancer patients and caregivers through support and education.

Lengte : 155

Perfect, uw meta description bevat tussen de 70 en 160 karakters.

Keywords

Erg slecht. We hebben geen meta keywords gevonden in uw website. Gebruik deze gratis online meta tags generator om keywords te genereren.

Og Meta Properties

Goed, uw page maakt gebruik van Og Properties.

Property Content
locale en_US
type website
title Get the Best Care for Your Chronic Lymphocytic Leukemia - CLL Society
description Addressing the unmet needs of the Chronic Lymphocytic Leukemia (CLL) community, our goal is to provide recent and relevant information for CLL patients.
url https://cllsociety.org/
site_name CLL Society
image https://cllsociety.org/wp-content/uploads/2022/04/CLL-Society-LOGO-w_Tag_Neon_Letter_cropped-300x226-1.png
image:width 300
image:height 226
image:type image/png

Headings

H1 H2 H3 H4 H5 H6
2 12 6 3 5 0
  • [H1] Meet our new research grantees
  • [H1] WELCOME
  • [H2] Actively Enrolling Clinical Trials in CLL
  • [H2] Support Our Work
  • [H2] Fast Find
  • [H2] Newly Diagnosed
  • [H2] Testing & Imaging
  • [H2] Treatment & Research
  • [H2] Medicine Cabinet
  • [H2] Support Groups
  • [H2] Free CLL Expert Opinion
  • [H2] Normal Lab Values & Tracker
  • [H2] Ask the Experts
  • [H2] What’s New in CLL / SLL?
  • [H3] From Diagnosis to Advocacy: Albie Suozzi’s CLL Journey Featured on the Cover of Cancer Health
  • [H3] Meet a New More Dangerous Doctor than Dr. Google: AI
  • [H3] Golf, 25 Years of CLL, and Long Remissions
  • [H3] CLL Patients are Immunocompromised, But What Does That Mean?
  • [H3] FDA Approves Combo of Acalabrutinib and Venetoclax in CLL
  • [H3] Epcoritamab Combination Therapies for Richter Transformation
  • [H4] LIVING WITH CLL
  • [H4] TREATMENT & RESEARCH
  • [H4] Privacy Overview
  • [H5] An investigational CAR-T option
  • [H5] Simplify Initiation, Discover More
  • [H5] A clinical study for BTK inhibitors resistance
  • [H5] A Study of an Investigational Agent in Mature B-Cell Malignancies
  • [H5] A Study of an Investigational Agent That Uses a Risk-Guided Approach for Relapsed CLL / SLL

Afbeeldingen

We vonden 30 afbeeldingen in de pagina.

19 alt attributen ontbreken. Voeg alternatieve text toe zodat zoekmachines beter kunnen beoordelen wat het onderwerp van de afbeeldingen is.

Text/HTML Ratio

Ratio : 4%

De ratio van text tot HTML code is below 15 procent, dit betekent dat uw pagina waarschijnlijk meer tekst nodig heeft.

Flash

Perfect, geen Flash content gevonden in uw website.

Iframe

Jammer, u heeft Iframes in uw website, dit betekent dat deze content niet kan worden geïndexeerd.

Herschreven URL

Perfect. Uw links zien er vriendelijk uit!

Underscores in de URLs

We hebben underscores gevonden in uw URLs. U zou het minteken moeten gebruiken ten behoeven van SEO.

In-page links

We vonden een totaal van 104 links inclusie 1 link(s) naar bestanden

Ankertekst Type samenstelling
Skip to content Intern doFollow
HOME Intern doFollow
What’s New Intern doFollow
Info & Mgmt Intern doFollow
Newly Diagnosed Intern doFollow
CLL / SLL Patient Education Toolkit Intern doFollow
Watch and Wait Intern doFollow
Build Your Care Team Intern doFollow
CLL Doctors Intern doFollow
CLL / SLL Symptoms Intern doFollow
Basic Biology of CLL Intern doFollow
Staging Intern doFollow
Complications Intern doFollow
CLL Testing & Imaging Intern doFollow
CLL Diagnosis Intern doFollow
Test Before Treat™ Intern doFollow
Treatment and Research Intern doFollow
Indications for Treatment Intern doFollow
CLL Medicine Cabinet Intern doFollow
Clinical Trials Intern doFollow
Clinical Trial Basics Intern doFollow
Opening Trials & Status Updates Intern doFollow
Clinical Trial Results Intern doFollow
The Patient Perspective Intern doFollow
Targeted Therapies Intern doFollow
Immunotherapy Intern doFollow
Chemotherapy Intern doFollow
CAR-T and Other Cellular Therapies Intern doFollow
Frontline Therapies Intern doFollow
Relapsed/Refractory or Later Therapies Intern doFollow
Richter’s Transformation Intern doFollow
MRD and Disease Monitoring Intern doFollow
CLL / SLL Resources Intern doFollow
Normal CLL Lab Values Intern doFollow
Keeping Track of Lab Results Intern doFollow
CLL Glossary Intern doFollow
CLL Abbreviations & Acronyms Intern doFollow
Ask the Experts Intern doFollow
Health Equity in CLL Intern doFollow
Opinions and Insights Intern doFollow
Regulatory News Intern doFollow
Programs & Support Intern doFollow
Support Groups Intern doFollow
1-on-1 Support Programs Intern doFollow
Upcoming Events Intern doFollow
Expert Access™ Intern doFollow
Education On-Demand Intern doFollow
CareCast Podcast Intern doFollow
COVID-19 Intern doFollow
COVID-19 Action Plan Intern doFollow
COVID-19 Updates Intern doFollow
COVID-19 Prevention & Treatment Intern doFollow
COVID-19 Official Statements Intern doFollow
COVID-19 Virtual Community Meetings Intern doFollow
COVID-19 General Information Intern doFollow
Living With CLL Intern doFollow
Stories and Testimonials Intern doFollow
Financial Resources Intern doFollow
Insurance Resources Intern doFollow
Mental and Physical Health Intern doFollow
Dr. Koffman’s Blogs Intern doFollow
Creative Corner Intern doFollow
Being Your Own Advocate Intern doFollow
Care Partners Intern doFollow
Veterans Intern doFollow
End of Life Planning Intern doFollow
Surveys Intern doFollow
About Us Intern doFollow
CLL Society in the News Intern doFollow
Our Story, Mission, and Vision Intern doFollow
Scientific Publications Intern doFollow
Board of Directors Intern doFollow
Medical Advisory Board Intern doFollow
Expert Medical Council Intern doFollow
International Partners Intern doFollow
Special Contributors Intern doFollow
Patient Advisory Board Intern doFollow
CLL Society Staff Intern doFollow
Volunteers Intern doFollow
Contact Us Intern doFollow
CLL Society Industry Advisory Council Intern doFollow
Research Intern doFollow
Current Funding Opportunities Intern doFollow
Apply for a Grant Intern doFollow
Eligibility Intern doFollow
Selection and Review Process Intern doFollow
Research Program Guidelines Intern doFollow
What We Fund Intern doFollow
Support Our Efforts Intern doFollow
Advocacy Intern doFollow
Needs of the Immunocompromised Intern doFollow
Access Intern doFollow
Innovation Intern doFollow
Donate Intern doFollow
Community Fundraising Intern doFollow
Celebrating Long Lives 5K Event Extern doFollow
Legacy Giving Intern doFollow
From Diagnosis to Advocacy: Albie Suozzi’s CLL Journey Featured on the Cover of Cancer Health Intern doFollow
Meet a New More Dangerous Doctor than Dr. Google: AI Intern doFollow
Golf, 25 Years of CLL, and Long Remissions Intern doFollow
CLL Patients are Immunocompromised, But What Does That Mean? Intern doFollow
FDA Approves Combo of Acalabrutinib and Venetoclax in CLL Intern doFollow
Epcoritamab Combination Therapies for Richter Transformation Intern doFollow
Site Design Extern doFollow

SEO Keywords

Keywords Cloud

clinical cll cookies research resources sll treatment cookie covid-19 support

Keywords Consistentie

Keyword Content Title Keywords Description Headings
cll 106
covid-19 28
cookies 24
sll 22
research 22

Bruikbaarheid

Url

Domein : cllsociety.org

Lengte : 14

Favicon

Goed, uw website heeft een favicon.

Printbaarheid

Jammer. We vonden geen Print-Vriendelijke CSS.

Taal

Goed. Uw ingestelde taal is en.

Dublin Core

Deze pagina maakt geen gebruik van Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Uw ingestelde Charset is UTF-8.

W3C Validiteit

Fouten : 0

Waarschuwingen : 0

E-mail Privacy

Geweldig er is geen e-mail adres gevonden als platte tekst!

Niet ondersteunde HTML

Geweldig! We hebben geen niet meer ondersteunde HTMl tags gevonden in uw HTML.

Speed Tips

Geweldig, uw website heeft geen tabellen in een tabel.
Jammer, uw website maakt gebruik van inline styles.
Geweldig, uw website heeft een correct aantal CSS bestanden.
Jammer, uw website heeft teveel JS bestanden (meer dan 6).
Perfect, uw website haalt voordeel uit gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimalisatie

XML Sitemap

Geweldig, uw website heeft een XML sitemap.

https://cllsociety.org/sitemap_index.xml

Robots.txt

https://cllsociety.org/robots.txt

Geweldig uw website heeft een robots.txt bestand.

Analytics

Perfect, uw website heeft een analytics tool.

   Google Analytics

PageSpeed Insights


Device
Categorieën

Free SEO Testing Tool

Website review is een gratis tool waarmee u eenvoudig uw website kunt analyseren